$2 Million Revenue, High-Growth Clinical Research Site in Texas
Clinical Research Site with Over 70 Awarded Trials in Texas
On NextCompany since August 27, 2026 (today)
TX area
Business overview
A full-service clinical research site conducts Phase II through IV trials in Texas. It has received more than 70 clinical trials and maintains over 20 active studies. Relationships with more than 15 pharmaceutical sponsors and CROs generate a pipeline. Approximately $1.5 million in signed-study revenue is expected over the next 12 months. Existing staff remain while the owner supports transition and expansion. Gross revenue reached approximately $2,000,000.
Who is a good fit for this business
- Strategic buyers seeking pharmaceutical sponsor relationships acquire this Texas research site.
- Acquirers wanting over 20 active studies and a $1.5 million pipeline fit this profile.
- Operators planning to scale a clinical research platform pursue this established business.
Details
Frequently Asked Questions
The site conducts Phase II through IV pharmaceutical, biotechnology, medical device, and diagnostic trials. Over 20 studies remain active.
Approximately $1.5 million in signed-study revenue is expected over the next 12 months. Gross revenue reached approximately $2,000,000. The owner supports transition and expansion.
Existing staff remain after acquisition. The owner supports transition and future growth.